Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies
| Autor: | Quinn, Dean, Barnes, Christopher N., Yates, Wayne, Bourdet, David L., Moran, Edmund J., Potgieter, Peter, Nicholls, Andrew, Haumann, Brett, Singh, Dave |
|---|---|
| Zdroj: | In Pulmonary Pharmacology & Therapeutics February 2018 48:71-79 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect